Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Takeda (Italy) | Researchclopedia

Back to institutions

Takeda (Italy)

Romecompany

65

Works

16,277

Citations

34

h-index

Top Research Topics

Lymphoma Diagnosis and Treatment Lung Cancer Treatments and Mutations Chronic Lymphocytic Leukemia Research

Top Researchers

Sverre E. Kjeldsen Oslo University Hospital

942 works104,548 citationsh-index: 102

Recent Research

[Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]

Rossella Bitonti,I Bozzari,et al.

20260 citations

Inflammatory Bowel Disease

Multiple Myeloma Research and Treatments

CAR-T cell therapy research

Diabetes Treatment and Management

Cancer Treatment and Pharmacology

Biosimilars and Bioanalytical Methods

Lung Cancer Diagnosis and Treatment

Gastric Cancer Management and Outcomes

Antibiotics Pharmacokinetics and Efficacy

A. Valero Universitat de València

1,461 works84,655 citationsh-index: 129

Giorgio Walter Canonica Humanitas University

1,729 works77,100 citationsh-index: 127

Nikolaos G. Papadopoulos National and Kapodistrian University of Athens

1,288 works71,630 citationsh-index: 117

Bertram Pitt Bayer (Germany)

859 works71,617 citationsh-index: 116

Antonio Palumbo University of Turin

612 works55,450 citationsh-index: 99

Psychometric validation of the quality of life Inventory − Disability (QI-Disability) among patients with Lennox-Gastaut syndrome and Dravet syndrome

Drishti Shah,Peter Jacoby,et al.

20250 citations

EE284 Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada

Libby Brook,Chloë Hardern,et al.

20250 citations

EE433 Evaluating the Annual Cost of Progression in CD30+ Cutaneous T-cell Lymphomas Following 2L+ Systemic Treatment in Italy

Loreto Spencer L.,Beatrice Canali,et al.

20250 citations

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity

Alessia Muzi,Roberto Arriga,et al.

20250 citations

Correction: Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy

Jonathan Salcedo,Daniel Hill‐McManus,et al.

20250 citations